“…The rationale of the method used has already been discussed by Beaugie and Samuel (I973)v The present observation that the administration of tubocurarine lowers the IOP does not agree with that of Sadove and Unna (I951), who claimed no change in the IOP after tubocurarine, but it supports those of Colle, Duke-Elder, and Duke-Elder (I93I), Kirby (1950), Roche (I950), and Kornblueth, Aladjemoff, Magora, and Gobbay (959), who reported varying degrees of fall in IOP after tubocurarine. The fall in IOP was attributed both to muscle paralysis and to the fall in blood pressure that accompanies the use of tubocurarine (Colle and others,193I).…”